Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patients

N. Cook; J. A. Bridgewater; M. P. Saunders; S. Kopetz; R. Garcia-Carbonero; S-H. Beom; B. H. O'Neil; R. H. Wilson; J. Graham; J. Maurel; T. W. Kim; I. Chau; S. Saleha; L. Goodwin; D. Wilson; J. Robertson; H. Timmis; E. Asken; S. A. Woodcock; V. Morris

doi:10.1016/j.annonc.2024.05.048

Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patients

N. Cook, J. A. Bridgewater, M. P. Saunders, S. Kopetz, R. Garcia-Carbonero, S-H. Beom, B. H. O'Neil, R. H. Wilson, J. Graham, J. Maurel, T. W. Kim, I. Chau, S. Saleha, L. Goodwin, D. Wilson, J. Robertson, H. Timmis, E. Asken, S. A. Woodcock, V. Morris

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S19-S20
Number of pages	2
Journal	Annals of Oncology
Volume	35
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/j.annonc.2024.05.048
Publication status	Published - 1 Jun 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.annonc.2024.05.048

Cite this

Cook, N., Bridgewater, J. A., Saunders, M. P., Kopetz, S., Garcia-Carbonero, R., Beom, S.-H., O'Neil, B. H., Wilson, R. H., Graham, J., Maurel, J., Kim, T. W., Chau, I., Saleha, S., Goodwin, L., Wilson, D., Robertson, J., Timmis, H., Asken, E., Woodcock, S. A., & Morris, V. (2024). Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patients. Annals of Oncology, 35(Supplement 1), S19-S20. https://doi.org/10.1016/j.annonc.2024.05.048

@article{f4b972a6424940f7bd03d181169b8620,

title = "Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patients",

author = "N. Cook and Bridgewater, {J. A.} and Saunders, {M. P.} and S. Kopetz and R. Garcia-Carbonero and S-H. Beom and O'Neil, {B. H.} and Wilson, {R. H.} and J. Graham and J. Maurel and Kim, {T. W.} and I. Chau and S. Saleha and L. Goodwin and D. Wilson and J. Robertson and H. Timmis and E. Asken and Woodcock, {S. A.} and V. Morris",

year = "2024",

month = jun,

day = "1",

doi = "10.1016/j.annonc.2024.05.048",

language = "English",

volume = "35",

pages = "S19--S20",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "Supplement 1",

}

Cook, N, Bridgewater, JA, Saunders, MP, Kopetz, S, Garcia-Carbonero, R, Beom, S-H, O'Neil, BH, Wilson, RH, Graham, J, Maurel, J, Kim, TW, Chau, I, Saleha, S, Goodwin, L, Wilson, D, Robertson, J, Timmis, H, Asken, E, Woodcock, SA & Morris, V 2024, 'Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patients', Annals of Oncology, vol. 35, no. Supplement 1, pp. S19-S20. https://doi.org/10.1016/j.annonc.2024.05.048

TY - JOUR

T1 - Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patients

AU - Cook, N.

AU - Bridgewater, J. A.

AU - Saunders, M. P.

AU - Kopetz, S.

AU - Garcia-Carbonero, R.

AU - Beom, S-H.

AU - O'Neil, B. H.

AU - Wilson, R. H.

AU - Graham, J.

AU - Maurel, J.

AU - Kim, T. W.

AU - Chau, I.

AU - Saleha, S.

AU - Goodwin, L.

AU - Wilson, D.

AU - Robertson, J.

AU - Timmis, H.

AU - Asken, E.

AU - Woodcock, S. A.

AU - Morris, V.

PY - 2024/6/1

Y1 - 2024/6/1

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001299993900037&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1016/j.annonc.2024.05.048

DO - 10.1016/j.annonc.2024.05.048

M3 - Meeting Abstract

SN - 0923-7534

VL - 35

SP - S19-S20

JO - Annals of Oncology

JF - Annals of Oncology

IS - Supplement 1

ER -

Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patients

UN SDGs

Access to Document

Other files and links

Cite this